Frances Theunissen

Perth, WA, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Entering the era of precision medicine to treat amyotrophic lateral sclerosis.

Entering the era of precision medicine to treat amyotrophic lateral sclerosis.

Journal: Molecular neurodegeneration

Published: March 26, 2025

The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy.

The Molecular Link Between TDP-43, Endogenous Retroviruses and Inflammatory Neurodegeneration in Amyotrophic Lateral Sclerosis: a Potential Target for Triumeq, an Antiretroviral Therapy.

Journal: Molecular neurobiology

Published: April 12, 2023

Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Synucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?

Journal: International journal of molecular sciences

Published: July 29, 2022

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset.

Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset.

Journal: Scientific reports

Published: March 16, 2022

Short structural variants as informative genetic markers for ALS disease risk and progression.

Short structural variants as informative genetic markers for ALS disease risk and progression.

Journal: BMC medicine

Published: September 29, 2021

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis.

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis.

Journal: Translational neurodegeneration

Published: August 29, 2021

Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype.

Novel STMN2 Variant Linked to Amyotrophic Lateral Sclerosis Risk and Clinical Phenotype.

Journal: Frontiers in aging neuroscience

Published: January 25, 2021

The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease.

The TOMM40 '523' polymorphism in disease risk and age of symptom onset in two independent cohorts of Parkinson's disease.

Journal: Scientific reports

Published: December 01, 2020

Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease.

Single Nucleotide Polymorphisms Associated With Gut Homeostasis Influence Risk and Age-at-Onset of Parkinson's Disease.

Journal: Frontiers in aging neuroscience

Published: September 08, 2020

Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort.

Disease-modifying effects of an SCAF4 structural variant in a predominantly SOD1 ALS cohort.

Journal: Neurology. Genetics

Published: February 19, 2020

Structural Variants May Be a Source of Missing Heritability in sALS.

Structural Variants May Be a Source of Missing Heritability in sALS.

Journal: Frontiers in neuroscience

Published: October 21, 2019

Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis.

Association of a structural variant within the SQSTM1 gene with amyotrophic lateral sclerosis.

Journal: Neurology. Genetics

Published: July 19, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026